Akouos

Akouos is developing AAV-based gene therapies to treat hearing loss that results from mutations in genes for inner ear function. Akouos uses specialized vectors and surgical procedures to target the inner ear.

Akouos has exclusive rights to AAV vectors that were designed specifically for diseases of the inner ear, hearing, and balance. For example, the company uses a vector called Anc8OL65 that transduces sensory cells and cochlear cells with high efficiency. Akouos delivers their gene therapies via minimally invasive surgery along the sensory epithelium, where target cells of the inner ear are located. The therapies work by various mechanisms, including delivery of a healthy gene in loss-of-function mutations, delivery of RNAi, and delivery of a protein that alters a disease pathway.

Jobs:

Sr. Engineer, Downstream Process Development

Boston, MA|22 days ago

Apply

Director, FP&A

Boston, MA|26 days ago

Apply

Director, Facilities and EH&S

Boston, MA|33 days ago

Apply

Director, Regulatory Project Management and Operations

Boston, MA|40 days ago

Apply

Translational Scientist

Boston, MA|100+ days ago

Apply

Tell Us About Yourself

Boston, MA|100+ days ago

Apply

Senior Vice President, Translational Research

Boston, MA|100+ days ago

Apply